Gilead Misses Revenue Estimates, Cuts Guidance

By: via Benzinga
Gilead Sciences, Inc. (NASDAQ: GILD) released its Q2 results after market close on Monday. Revenues came in above Wall Street ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.